Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022

SELL
$25.68 - $35.59 $1.09 Million - $1.51 Million
-42,375 Closed
0 $0
Q4 2021

Jan 21, 2022

SELL
$24.9 - $40.26 $314,312 - $508,201
-12,623 Reduced 22.95%
42,375 $1.24 Million
Q3 2021

Nov 08, 2021

BUY
$25.48 - $37.34 $618,832 - $906,876
24,287 Added 79.08%
54,998 $1.4 Million
Q2 2021

Aug 04, 2021

SELL
$32.46 - $43.42 $93,582 - $125,179
-2,883 Reduced 8.58%
30,711 $1.08 Million
Q1 2021

May 10, 2021

SELL
$38.94 - $50.85 $469,850 - $613,556
-12,066 Reduced 26.43%
33,594 $1.37 Million
Q4 2020

Feb 08, 2021

BUY
$37.65 - $63.77 $1.72 Million - $2.91 Million
45,660 New
45,660 $1.98 Million
Q3 2020

Nov 09, 2020

SELL
$52.76 - $74.49 $1.61 Million - $2.27 Million
-30,434 Closed
0 $0
Q2 2020

Aug 05, 2020

SELL
$48.73 - $81.82 $2 Million - $3.37 Million
-41,135 Reduced 57.48%
30,434 $1.92 Million
Q1 2020

May 06, 2020

BUY
$41.72 - $87.2 $663,723 - $1.39 Million
15,909 Added 28.58%
71,569 $3.66 Million
Q4 2019

Jan 29, 2020

BUY
$45.7 - $81.86 $959,517 - $1.72 Million
20,996 Added 60.57%
55,660 $4.42 Million
Q3 2019

Nov 01, 2019

BUY
$45.35 - $57.91 $6,394 - $8,165
141 Added 0.41%
34,664 $1.68 Million
Q2 2019

Aug 09, 2019

SELL
$52.6 - $63.29 $90,524 - $108,922
-1,721 Reduced 4.75%
34,523 $1.82 Million
Q1 2019

May 13, 2019

BUY
$39.99 - $53.48 $128,767 - $172,205
3,220 Added 9.75%
36,244 $1.92 Million
Q4 2018

Feb 11, 2019

SELL
$31.54 - $46.67 $221,095 - $327,156
-7,010 Reduced 17.51%
33,024 $1.36 Million
Q3 2018

Oct 26, 2018

BUY
$38.0 - $51.1 $571,406 - $768,390
15,037 Added 60.16%
40,034 $1.52 Million
Q1 2018

May 11, 2018

SELL
$39.6 - $65.9 $257,637 - $428,745
-6,506 Reduced 20.65%
24,997 $1.21 Million
Q4 2017

Feb 06, 2018

SELL
$29.7 - $45.7 $783,337 - $1.21 Million
-26,375 Reduced 45.57%
31,503 $1.28 Million
Q3 2017

Nov 07, 2017

BUY
$25.1 - $31.05 $1.45 Million - $1.8 Million
57,878
57,878 $1.8 Million

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.